Safety and efficacy of the available oral anti diabetic drugs in treating type-2 diabetics during Ramadan1437(Hijri)fasting in Fayoum Governate | ||||
Fayoum University Medical Journal | ||||
Article 1, Volume 1, Issue 1, March 2018, Page 49-67 PDF (920.2 K) | ||||
Document Type: Full Length research Papers | ||||
DOI: 10.21608/fumj.2018.5429 | ||||
View on SCiNiTO | ||||
Authors | ||||
Mohamed Abd elHady Mashahit 1; Sally Abo El-seoud2; Norhan Sayed2; Noha Abd El-Ghafar3 | ||||
1Prof of internal medicin Fayoum | ||||
2Department of Internal Medicine, Faculty of Medicine, Fayoum University, Egypt | ||||
3Department of Clinical Pathology , Faculty of Medicine, Fayoum University, Egypt | ||||
Abstract | ||||
Introduction : Fasting in Ramadan is one of the five pillars of Islam. Without relevant medical advice and intervention, fasting can put patients with T2DM at an increased risk of serious complications. The aim of this study was to compare the effectiveness and safety of available oral anti diabetic drugs in treating type-2 diabetics during Ramadan fasting. Methods : In this 16-week prospective study, data were collected up to 6 weeks before and after Ramadan fasting . Patients who had received metformin alone or with sulfonylurea (SU), DPP4-I or TZDs or any combination of the before were enrolled into the study. Results : This study concluded that mean total HbA1c improved during Ramadan (𝑃<0.001 ) . This study also found that patients treated with SUs experienced major hypoglycemic events Similarly, a fewer patients experienced weight gain when treated with TZDs. On the contrary we found that there was no evidence of hyperglycemia or hypoglycemia in patients using DPP4-I. Conclusions: There are several potential benefits of fasting during Ramadan. Active glucose monitoring throughout the holy month of Ramadan enabled us to pick up more hypoglycaemic episodes .The study revealed that the preferred antidiabetic drugs during Ramadan are DPP4-I. | ||||
Keywords | ||||
DPP4 inhibitors; Hypoglycemia; sulphonylureas; Type 2 diabetes mellitus; TZDs; Metformin | ||||
Statistics Article View: 354 PDF Download: 497 |
||||